San Francisco Bay Area biotech stories.
Monday, July 16, 2012
FDA approves Gilead's Truvada as first pill for HIV prevention
Gilead Sciences Inc.'s HIV-fighting pill Truvada was approved Monday to prevent transmission of the AIDS virus.
It is the first agent to be approved for HIV prevention in uninfected adults, said Foster City-based Gilead (NASDAQ: GILD).
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)